Impurity Insights, a US Pharmacopoeia Initiative in collaboration with the Society for Pharmaceutical Dissolution Science (SPDS) and the Department of Pharmaceutical Analysis, Institute of Pharmacy, Nirma University was organized on Thursday, 25 January 2024 at Institute of Pharmacy, Nirma University, Ahmedabad.
The seminar delved into the intricacies of managing organic and inorganic impurities with a focus on key USP General Chapters.
Series of talks on topics ranging from the International harmonization process for USP general chapter <621> to Impurities & Forced Degradation studies as well as value beyond Vials & Risks associated with secondary standards to name a few. It also emphasized the significance of Pharmaceutical Analytical Impurities (PAI), and Reference Standards (RS).
Dr. Antonio Hernandez Cardoso, Senior Principal Scientist, USP; Dr. Mukesh Kumar, Founder Director, Otriv-Q3 Research Pvt. Ltd and representative of SPDS; Dr. Ravi Reddy, Vice President, RSD group, USP and Dr Kailash Asati, Zydus Lifesciences Ltd. addressed the audience.
Mr. R. Kartik Iyer, Associate Director, Strategic Customer Development, USP; Ms. Zeenat Khan, Associate Director, SCD and Mr. KRC Reddy, Chief Business Officer, Chromachemie India Pvt. Ltd. were also present.
Delegates from various pharmaceutical industries, faculty, and students of the Institute of Pharmacy, Nirma University actively participated in the seminar.
Dr. Nrupesh Patel and Prof. Priti Mehta, from the Department of Pharmaceutical Analysis, coordinated the program from the Institute of Pharmacy.
